Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 229

    1.

    Barriers to efficient development of cancer therapeutics.

    Schein PS, Scheffler B.

    Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3243-8. Review. No abstract available. PMID: 16740743 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The role of the FDA in the national cancer program: friend or foe?

    Schein PS, Scheffler B, Carter S.

    Oncologist. 2003;8(6):501-6. No abstract available. PMID: 14657526 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The case for a new national program for the development of cancer therapeutics.

    Schein PS.

    J Clin Oncol. 2001 Jun 15;19(12):3142-53. No abstract available. PMID: 11408512 [PubMed - indexed for MEDLINE]Related articles

    4.

    Use of amifostine in bone marrow purging.

    Cagnoni PJ, Jones RB, Bearman SI, Ross M, Hami L, Franklin WA, Capizzi R, Schein PS, Shpall EJ.

    Semin Oncol. 1996 Aug;23(4 Suppl 8):44-8.PMID: 8783666 [PubMed - indexed for MEDLINE]Related articles

    5.

    Organic thiophosphate WR-151327 suppresses expression of HIV in chronically infected cells.

    Kalebic T, Schein PS.

    AIDS Res Hum Retroviruses. 1994 Jun;10(6):727-33.PMID: 7521193 [PubMed - indexed for MEDLINE]Related articles

    6.

    Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy.

    Capizzi RL, Scheffler BJ, Schein PS.

    Cancer. 1993 Dec 1;72(11 Suppl):3495-501. Review.PMID: 8242582 [PubMed - indexed for MEDLINE]Related articles

    7.

    The role of hexamethylmelamine in the management of ovarian cancer.

    Schein PS, Scheffler B, McCulloch W.

    Cancer Treat Rev. 1991 Mar;18 Suppl A:67-75. Review.PMID: 1904311 [PubMed - indexed for MEDLINE]Related articles

    8.

    New protective agents for bone marrow in cancer therapy.

    McCulloch W, Scheffler BJ, Schein PS.

    Cancer Invest. 1991;9(3):279-87. Review.PMID: 1655173 [PubMed - indexed for MEDLINE]Related articles

    9.

    New sugar mitomycin C analogues: preparation, murine P388 antitumor activity, and leukopenia induction.

    Talebian A, Green D, Hammer CF, McPherson E, Schein PS.

    J Pharm Sci. 1990 Dec;79(12):1105-8.PMID: 2127804 [PubMed - indexed for MEDLINE]Related articles

    10.

    Murine anti-tumor activity of new water soluble platinum(II) complexes with reduced toxicity.

    Talebian AH, Bensely D, Schein PS, Green D.

    Anticancer Drug Des. 1990 Nov;5(4):371-8.PMID: 2291775 [PubMed - indexed for MEDLINE]Related articles

    11.

    A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

    Coombes RC, Schein PS, Chilvers CE, Wils J, Beretta G, Bliss JM, Rutten A, Amadori D, Cortes-Funes H, Villar-Grimalt A, et al.

    J Clin Oncol. 1990 Aug;8(8):1362-9.PMID: 2199622 [PubMed - indexed for MEDLINE]Related articles

    12.

    Phase I study of oral spirogermanium.

    Harvey J, McFadden M, Smith FP, Joubert L, Schein PS.

    Invest New Drugs. 1990 Feb;8(1):53-6.PMID: 2345069 [PubMed - indexed for MEDLINE]Related articles

    13.

    WR-2721: a chemotherapy and radiation-protective agent.

    Schein PS.

    Cancer Invest. 1990;8(2):265-6. No abstract available. PMID: 2169331 [PubMed - indexed for MEDLINE]Related articles

    14.

    6-bis-(2-chloroethyl)amino-6-deoxy-D-galactopyranose hydrochloride: synthesis, chemical characterization, murine P388 antitumor activity, and bone marrow toxicity.

    Schein PS, Green D, Hammer CF, McPherson E, Talebian A.

    J Pharm Sci. 1989 Nov;78(11):918-21.PMID: 2621574 [PubMed - indexed for MEDLINE]Related articles

    15.

    Lack of common haplotype among four family members with late-onset Kaposi's sarcoma.

    Neefe JR, Treat JA, Chun BK, Schein PS, Johnson AH.

    J Immunogenet. 1989 Jun;16(3):247-50.PMID: 2614074 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.

    Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV, Chiazze L, Schein PS, et al.

    J Clin Oncol. 1989 Jun;7(6):781-9. Review.PMID: 2497229 [PubMed - indexed for MEDLINE]Related articles

    17.

    Therapy of advanced gastric carcinoma. The Georgetown-Lombardi Cancer Center experience.

    Treat J, Falchuk SC, Woolley PV, Ahlgren JD, Neefe JR, Smith FP, Macdonald JS, Schein PS.

    Am J Clin Oncol. 1989 Apr;12(2):162-8.PMID: 2523188 [PubMed - indexed for MEDLINE]Related articles

    18.

    Unique sensitivity of nitrogen mustard-resistant human Burkitt lymphoma cells to novobiocin.

    Tan KB, Mattern MR, Boyce RA, Schein PS.

    Biochem Pharmacol. 1988 Nov 15;37(22):4411-3. No abstract available. PMID: 2848528 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.

    McCabe M, Smith FP, Macdonald JS, Woolley PV, Goldberg D, Schein PS.

    Invest New Drugs. 1988 Sep;6(3):243-6.PMID: 2847994 [PubMed - indexed for MEDLINE]Related articles

    20.

    Chemotherapy of gastric cancer.

    Schein PS.

    Acta Chir Scand Suppl. 1988;541:13-5. No abstract available. PMID: 2455406 [PubMed - indexed for MEDLINE]Related articles

    21.

    Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.

    Tan KB, Mattern MR, Boyce RA, Schein PS.

    Proc Natl Acad Sci U S A. 1987 Nov;84(21):7668-71.PMID: 2823270 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.

    Ahlgren JD, Smith FP, Cazap E, Estevez RA, Marantz A, Woolley PV, Wilcosky T, Stein J, Schein PS.

    Cancer Treat Rep. 1987 Apr;71(4):419-20. No abstract available. PMID: 3548959 [PubMed - indexed for MEDLINE]Related articles

    23.

    6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.

    Schein PS, Green D, Dean SW, McPherson E.

    Cancer Res. 1987 Feb 1;47(3):696-9.PMID: 3802075 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Chemotherapy of gastric carcinoma.

    Schein PS.

    Eur J Surg Oncol. 1987 Feb;13(1):3-10. Review. No abstract available. PMID: 3545906 [PubMed - indexed for MEDLINE]Related articles

    25.

    Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells.

    Tan KB, Mattern MR, Boyce RA, Hertzberg RP, Schein PS.

    NCI Monogr. 1987;(4):95-8.PMID: 2819739 [PubMed - indexed for MEDLINE]Related articles

    26.

    Endocrine tumors.

    van der Hoeven JJ, Schein PS.

    Cancer Chemother Biol Response Modif. 1987;9:271-9. Review. No abstract available. PMID: 2484325 [PubMed - indexed for MEDLINE]Related articles

    27.

    Oncolipids? A possible new approach to diagnosis of cancer.

    Schein PS.

    N Engl J Med. 1986 Nov 27;315(22):1410-1. No abstract available. PMID: 3773966 [PubMed - indexed for MEDLINE]Related articles

    28.

    Cellular pharmacology of mu-[1,2-bis(diphenylphosphino)ethane]bis[(1-thio-beta-D-gluco pyranosato-S)gold(I)]: a novel antitumor agent.

    Mirabelli CK, Jensen BD, Mattern MR, Sung CM, Mong SM, Hill DT, Dean SW, Schein PS, Johnson RK, Crooke ST.

    Anticancer Drug Des. 1986 Nov;1(3):223-34.PMID: 3450295 [PubMed - indexed for MEDLINE]Related articles

    29.

    The current state of chemotherapy in gastric cancer.

    Schein PS.

    Eur J Surg Oncol. 1986 Sep;12(3):251-2. No abstract available. PMID: 3758362 [PubMed - indexed for MEDLINE]Related articles

    30.

    Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach.

    Cazap EL, Gisselbrecht C, Smith FP, Estevez RA, Alvarez CA, Lagarde C, Hannois A, Ahmed S, Schein PS, Woolley PV.

    Cancer Treat Rep. 1986 Jun;70(6):781-3.PMID: 3524826 [PubMed - indexed for MEDLINE]Related articles

    31.

    Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.

    Cantrell JE Jr, Green D, Schein PS.

    Cancer Res. 1986 May;46(5):2340-3.PMID: 2938728 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Prednimustine: the rationale for clinical development.

    Schein PS, Cavalli F.

    Semin Oncol. 1986 Mar;13(1 Suppl 1):1-2. No abstract available. PMID: 3952515 [PubMed - indexed for MEDLINE]Related articles

    33.

    5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.

    Goldberg RM, Smith FP, Ueno W, Ahlgren JD, Schein PS.

    J Clin Oncol. 1986 Mar;4(3):395-9.PMID: 3754004 [PubMed - indexed for MEDLINE]Related articles

    34.

    Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion.

    Korec S, Schein PS, Smith FP, Neefe JR, Woolley PV, Goldberg RM, Phillips TM.

    J Clin Oncol. 1986 Feb;4(2):210-5.PMID: 3944604 [PubMed - indexed for MEDLINE]Related articles

    35.

    Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.

    Rahman A, Fumagalli A, Barbieri B, Schein PS, Casazza AM.

    Cancer Chemother Pharmacol. 1986;16(1):22-7.PMID: 3940217 [PubMed - indexed for MEDLINE]Related articles

    36.

    Recognition of hepatitis B surface antigen by the human hepatoma cell line HepG2.

    Kaiser J, Stockert RJ, Schein PS, Wolkoff AW.

    Trans Assoc Am Physicians. 1986;99:86-91. No abstract available. PMID: 3037754 [PubMed - indexed for MEDLINE]Related articles

    37.

    Contributions of nitrosoureas to cancer treatment.

    Mitchell EP, Schein PS.

    Cancer Treat Rep. 1986 Jan;70(1):31-41. Review. No abstract available. PMID: 3002621 [PubMed - indexed for MEDLINE]Related articles

    38.

    The role of chemotherapy in the management of gastric and pancreatic carcinomas.

    Schein PS.

    Semin Oncol. 1985 Dec;12(4 Suppl 6):49-60. Review.PMID: 3936182 [PubMed - indexed for MEDLINE]Related articles

    39.

    DNA repeat length in chromatin from murine bone marrow and L1210 leukaemia cells.

    Dean SW, Tew KD, Clark AE, Schein PS.

    Br J Cancer. 1985 Sep;52(3):377-82.PMID: 2931097 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Carcinoid carcinomatous meningitis.

    Nagourney RA, Hedaya R, Linnoila M, Schein PS.

    Ann Intern Med. 1985 Jun;102(6):779-82.PMID: 2581491 [PubMed - indexed for MEDLINE]Related articles

    41.

    Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.

    Cantrell JE Jr, Phillips TM, Schein PS.

    J Clin Oncol. 1985 May;3(5):723-34.PMID: 3923162 [PubMed - indexed for MEDLINE]Related articles

    42.

    Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma.

    Le Chevalier T, Smith FP, Harter WK, Schein PS.

    Semin Oncol. 1985 Mar;12(1):46-53. Review. No abstract available. PMID: 3883501 [PubMed - indexed for MEDLINE]Related articles

    43.

    Selective inhibition of cardiac cyclic nucleotide phosphodiesterases by doxorubicin and daunorubicin.

    Law J, Fumagalli A, Schein PS, Rahman A.

    Life Sci. 1985 Feb 11;36(6):589-99.PMID: 2982070 [PubMed - indexed for MEDLINE]Related articles

    44.

    Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.

    Rahman A, White G, More N, Schein PS.

    Cancer Res. 1985 Feb;45(2):796-803.PMID: 3967247 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracil.

    Woolley PV, Ayoob MJ, Smith FP, Lokey JL, DeGreen P, Marantz A, Schein PS.

    J Clin Oncol. 1985 Jan;3(1):103-9.PMID: 3965628 [PubMed - indexed for MEDLINE]Related articles

    46.

    The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer.

    Posada JG Jr, Marantz AB, Yeung KY, Smith FP, Delgado G, Edwards BK, Schein PS.

    Gynecol Oncol. 1985 Jan;20(1):23-31.PMID: 3917421 [PubMed - indexed for MEDLINE]Related articles

    47.

    Therapy of gastrointestinal cancer.

    Greig RG, Schein PS.

    Scand J Gastroenterol Suppl. 1985;117:9-25. Review.PMID: 3912966 [PubMed - indexed for MEDLINE]Related articles

    48.

    Enhanced nitrosourea cytotoxicity in cell culture by sodium butyrate.

    Vu VT, Moy BC, Schein PS, Tew KD.

    Oncology. 1985;42(5):317-21.PMID: 3162128 [PubMed - indexed for MEDLINE]Related articles

    49.

    Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity.

    Rahman A, Fumagalli A, Goodman A, Schein PS.

    Semin Oncol. 1984 Dec;11(4 Suppl 3):45-55. No abstract available. PMID: 6594763 [PubMed - indexed for MEDLINE]Related articles

    50.

    Presidential address: the plight of clinical cancer research.

    Schein PS.

    J Clin Oncol. 1984 Dec;2(12):1433-9. No abstract available. PMID: 6512587 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...